Entera Bio Ltd (STU:5DT)
€ 1.58 -0.01 (-0.62%) Market Cap: 58.65 Mil Enterprise Value: 50.51 Mil PE Ratio: 0 PB Ratio: 7.36 GF Score: 40/100

Q4 2021 Entera Bio Ltd Earnings Call Transcript

Mar 08, 2022 / 01:30PM GMT
Release Date Price: €2.04 (+6.25%)
Operator

Greetings, and welcome to the Entera Bio Fourth Quarter and Year-End 2021 Earnings Call. (Operator Instructions) As a reminder, this conference is being recorded. I would now like to turn the call over to Ramesh Ratan, Chief Financial Officer. Thank you. You may begin.

Ramesh Ratan
Entera Bio Ltd. - U.S. CFO

Good morning, and welcome to the call. Joining me on today's call are Spiros Jamas, our CEO; Arthur Santora, our Chief Medical Officer; and Phillip Schwartz, our Founder and President of R&D. Our press release announcing Entera's financial and operating results for the full year ended December 31, 2021, was issued this morning. For those of you who have not yet seen it, it's available on the Investors section of our website, www.enterabio.com.

On our call this morning, we will share with you a business update and review of our financial results, which will be followed by a question-and-answer session. Before we begin our prepared remarks, I'd like to remind you that various

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot